Skip to main content

IDWeek 2023 Main banner

Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

243 Views

240. New Antimicrobial Drug Development: Saturday, 12:15 - 1:30 p.m.

Poster Session: New Antimicrobial Drug Development

(2524) Safety and Pharmacokinetics of PA-001, a New Potential COVID-19 Drug That Targets the S2 Subunit of SARS-CoV-2 Spike Protein, in Healthy Subjects

Saturday, October 14, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

HK

Haruaki Kurasaki, PhD

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
MO

Masaki Ohuchi, PhD

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
KM

Katsuma Matsui, PhD

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
MM

Masatoshi Matsumoto, PhD

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
KN

Kazutaka Nagatomo, PhD

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
NK

Naoki Kawamura, MSc

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
SI

Shoko Ito, MSc

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
TY

Takuma Yonemura, MD

SOUSEIKAI Sumida Hospital
Tokyo, Tokyo, Japan
TC

Takeshi Chiyoda, PhD

SOUSEIKAI Sumida Hospital
Tokyo, Tokyo, Japan
AY

Asuka Yamamoto, BSc

SOUSEIKAI Sumida Hospital
Tokyo, Tokyo, Japan
AS

Akihito Shimoi, PhD, DVM

Ina Research Inc.
Ina, Nagano, Japan
KM

Keiichi Masuya, PhD

PeptiAID Inc.
Kawasaki, Kanagawa, Japan
HK

Hidetomo Kitamura, PhD, DVM

PeptiDream Inc.
Kawasaki, Kanagawa, Japan

Presenting Author(s)

Masato Murakami, MD, PhD (he/him/his)

CMO
PeptiDream Inc.
Kawasaki-shi, Kanagawa, Japan